NASDAQ: DERM - Journey Medical Corporation

Yield per half year: +3.52%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Journey Medical Corporation

Extended chart Simple chart
Financial Markets by TradingView

About Journey Medical Corporation

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States.

more details
The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an oral doxycycline drug for adjunctive therapy for severe acne; Zilxi, a topical minocycline treatment for inflammatory lesions; Ximino, an oral minocycline drug for the treatment of moderate to severe acne; and Exelderm cream and solution for topical use. It also sells doxycycline hyclate tablets, minocycline hydrocholoride capsules, and sulconazole nitrate cream and solution. The company was formerly known as Coronado Dermatology, Inc. and changed its name to Journey Medical Corporation. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona. Journey Medical Corporation is a subsidiary of Fortress Biotech, Inc.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-11-12
ISIN US48115J1097
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://journeymedicalcorp.com
Цена ао 6.14
Change price per day: -0.4831% (6.21)
Change price per week: -5.5% (6.54)
Change price per month: +16.38% (5.31)
Change price per 3 month: +60.94% (3.84)
Change price per half year: +3.52% (5.97)
Change price per year: +60.1% (3.86)
Change price per 3 year: +26.38% (4.89)
Change price per year to date: +32.05% (4.68)
All parameters

Underestimation

Title Value Grade
P/S 1.6 8
P/BV 6.23 1
P/E 0 0
EV/EBITDA 23.76 5
Total: 3.25

Efficiency

Title Value Grade
ROA, % -5.01 0
ROE, % -18.93 0
Total: 0.6667

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0.6986

Debt

Title Value Grade
Debt/EBITDA 3.6 3
Total: 7.6

Growth impulse

Title Value Grade
Yield Revenue, % 126.88 10
Yield Ebitda, % -70.45 0
Yield EPS, % -195.84 0
Total: 2
More

Institutions Volume Share, %
Renaissance Technologies, LLC 261000 1.87
American Financial Group Inc. 180000 1.29
Vanguard Group Inc 129448 0.93
EAM Investors, LLC 110509 0.79
Neuberger Berman Group, LLC 94479 0.68
Geode Capital Management, LLC 85785 0.62
Millennium Management LLC 75031 0.54
Blackrock Inc. 43892 0.32
NewEdge Advisors, LLC 36592 0.26
Perkins Capital Management, Inc. 32000 0.23



Head Job title Payment Year of birth
Dr. Lindsay Allan Rosenwald Executive Chairman 50k 1955 (70 years)
Mr. Claude Maraoui Founder, President, CEO & Director 934.45k 1967 (58 years)
Mr. Joseph M. Benesch CFO & Corporate Controller 409.04k 1967 (58 years)
Mr. Andrew J. Zwible Vice President of Operations N/A
Mr. Ramsey Alloush General Counsel & Company Secretary N/A 1986 (39 years)
Mr. Robert Nevin Chief Commercial Officer N/A 1968 (57 years)
Jaclyn Jaffe Senior Director of Corporate Operations N/A

Address: United States, Scottsdale. AZ, 9237 East Via de Ventura Boulevard - open in Google maps, open in Yandex maps
Website: https://journeymedicalcorp.com